Biology42: Generative Biologics
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Find alternatives to Biology42: Generative Biologics
What it does
- Drug discovery
- Model training
Features 6
- De Novo GenerationDesigns binders for hard targets and desired epitopes de novo.
- Template-based generationGenerates novel, improved 3D variants of an existing binder.
- Optimization workflowOptimizes multiple properties of candidates simultaneously, balancing affinity and developability.
- Model trainingTrain property- and project-specific predictive models on your own data.
- Prediction workflowSelects candidates with desired properties for further development.
- Built-in predictive modelsPre-trained models predict and optimize developability properties.
Sources
- Pricing
-
Official documentation · 3 Sep 2026
Contact-and-consultation model only. Page's own heading is 'Biology42: Generative Biologics'; suite nav shortens this to 'Generative Biologics'.
- Constraints
-
Official documentation · 2 Oct 2026
Derived from the security facts on this page, from the same source.
- Security
-
Official documentation · 2 Oct 2026
Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.
- Sold within
-
Official documentation · 15 Sep 2026
pharma.ai/generativebiologics (already cited official-docs elsewhere on this record); standalone technology access or combined with Pharma.ai collaborations, no restriction.
Also from Insilico Medicine
-
Pharma.AI Platform
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base; also answers literature-review questions through ChatPandaGPT.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-generative-biologics.